Convatec GroupFRA:2CV +1.63%77 EV-to-FCF is 25.02 as of Jun. 30, 2026, which is 14% below its 10-year median of 29.18. GuruFocus rates FRA:2CV with a GF Score™ of 77/100 and a GF Value™ of €2.96. The stock has 4 warning signs investors should review. Among 419 Medical Devices & Instruments companies, Convatec Group ranks worse than 53.94% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Convatec Group's Enterprise Value is €6,117 Mil.
Convatec Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €245 Mil. Therefore, Convatec Group's EV-to-FCF for today is 25.02.
The historical rank and industry rank for Convatec Group's EV-to-FCF or its related term are showing as below:
FRA:2CV'
s EV-to-FCF Range Over the Past 10 Years
Min: 15.25 Med: 29.18 Max: 1056.92
Current: 24.69
During the past 13 years, the highest EV-to-FCF of Convatec Group was 1056.92. The lowest was 15.25. And the median was 29.18.
FRA:2CV's EV-to-FCF is ranked worse than 53.94% of 419
companies
in the Medical Devices & Instruments industry
Industry Median: 22.57
vs FRA:2CV: 24.69
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Convatec Group's PE Ratio (TTM) for today is calculated as:
Convatec Group's share price for today is €2.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Convatec Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.074.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Convatec Group EV-to-FCF Related Terms
Convatec Group EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Convatec Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Convatec Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Convatec Group EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Convatec Group's EV-to-FCF falls into.
Convatec Group's current Enterprise Value is €6,117 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Convatec Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €245 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Convatec Group (FRA:2CV) has a EV-to-FCF of 25.02 as of Jun. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Convatec Group and its competitors. This is 14% below median its historical median of 29.18. Over the past decade, Convatec Group's EV-to-FCF has ranged from 15.25 to 1,056.92. According to the industry distribution chart, Convatec Group ranks #226 out of 419 companies in the Medical Devices & Instruments industry, placing it in the top 53.9%.
Is Convatec Group's EV-to-FCF too high?
Convatec Group's current EV-to-FCF of 25.02 is 14% below median its 10-year median of 29.18. Over the past 10 years, this metric has ranged from a low of 15.25 to a high of 1,056.92. The Medical Devices & Instruments industry median EV-to-FCF is 22.57. Convatec Group's value of 25.02 is 10.9% above this industry median. Based on the distribution chart, Convatec Group ranks #226 out of 419 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Convatec Group has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Convatec Group ranks #226 out of 419 companies for EV-to-FCF. This places Convatec Group in the lower half of its industry. The industry median EV-to-FCF is 22.57. Convatec Group's value of 25.02 is 10.9% above this benchmark. Historically, Convatec Group's own EV-to-FCF has ranged from 15.25 to 1,056.92 over the past decade. While the company's 10-year median is 29.18 vs. the industry median of 22.57, Convatec Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.57, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Convatec Group's current EV-to-FCF of 25.02 is 10.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Convatec Group and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Convatec Group's current EV-to-FCF is 25.02, which is 14% below median its own 10-year median of 29.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Convatec Group (FRA:2CV) has a current EV-to-FCF of 25.02. The stock's GF Value™ is €2.96, compared to a current price of €2.50 — trading 15.5% below its estimated fair value. The current EV-to-FCF is 25.02, which is 14% below median its 10-year median of 29.18 and 10.9% above the Medical Devices & Instruments industry median of 22.57. Convatec Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Convatec Group (FRA:2CV), the current EV-to-FCF is 25.02 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Convatec Group (FRA:2CV) Overvalued in 2026?
Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued.
The current stock price of €2.50 is trading 15.5% below its estimated GF Value™ of €2.96.
Key valuation signals for FRA:2CV:
EV-to-FCF: 25.02 (14% below median its 10-year median of 29.18)
GF Value™: €2.96 vs. price of €2.50 (15.5% below fair value)
Industry Position: 10.9% above the Medical Devices & Instruments median (#226 of 419)
No single metric tells the full story. See the FRA:2CV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
77GF Score
Get the complete analysis for FRA:2CV
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2CV has been successfully added to your 
